Prostate adenocarcinoma with mucinous features – is it PSMA avid?

Summary Mucinous prostate adenocarcinoma represents

Saved in:
Bibliographic Details
Published in:Journal of medical imaging and radiation oncology 2022-08, Vol.66 (5), p.637-640
Main Authors: Horsley, Patrick J., Sheehan‐Dare, Gemma, Mastrocostas, Katerina, Fung, Caroline, Kneebone, Andrew, Eade, Thomas N., Emmet, Louise, Lalak, Andre, Hruby, George
Format: Article
Language:English
Subjects:
adenocarcinoma
Deprivation
Medical imaging
mucinous
Prostate
Prostate cancer
PSMA‐PET
Radiation therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2697-acbf0caef06bd9478e19b88861d42fc7edb938ebd43cbb456b91143ca4a5a7a63
container_end_page 640
container_issue 5
container_start_page 637
container_title Journal of medical imaging and radiation oncology
container_volume 66
creator Horsley, Patrick J.
Sheehan‐Dare, Gemma
Mastrocostas, Katerina
Fung, Caroline
Kneebone, Andrew
Eade, Thomas N.
Emmet, Louise
Lalak, Andre
Hruby, George
description Summary Mucinous prostate adenocarcinoma represents
doi_str_mv 10.1111/1754-9485.13327
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2697589587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2697589587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2697-acbf0caef06bd9478e19b88861d42fc7edb938ebd43cbb456b91143ca4a5a7a63</originalsourceid><addsrcrecordid>eNqFUMtOwzAQtBBIlMKZqyXOaePGju0TiiooSEVUPM7W2nGEq7YpdkLVG__AH_IlOAT1yl72oZmd3UHokqQjEmNMOKOJpIKNSJZN-BEaHCbHh5rzU3QWwjJNc0KoHKDpwtehgcZiKO2mNuCN29RrwDvXvOF123VtwJWFpvU24O_PL-wCdg1ePD8UGD5ceX2OTipYBXvxl4fo9fbmZXqXzB9n99NinphJLnkCRlepAVuluS7jKcISqYUQOSnppDLcllpmwuqSZkZrynIt442ZAQoMOOTZEF31e7e-fm9taNSybv0mSqpOgAnJBI-ocY8y8bPgbaW23q3B7xVJVeeU6rxQnS_q16nIYD1j51Z2_x9cFU9Fz_sB0udrQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2697589587</pqid></control><display><type>article</type><title>Prostate adenocarcinoma with mucinous features – is it PSMA avid?</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Horsley, Patrick J. ; Sheehan‐Dare, Gemma ; Mastrocostas, Katerina ; Fung, Caroline ; Kneebone, Andrew ; Eade, Thomas N. ; Emmet, Louise ; Lalak, Andre ; Hruby, George</creator><creatorcontrib>Horsley, Patrick J. ; Sheehan‐Dare, Gemma ; Mastrocostas, Katerina ; Fung, Caroline ; Kneebone, Andrew ; Eade, Thomas N. ; Emmet, Louise ; Lalak, Andre ; Hruby, George</creatorcontrib><description>Summary Mucinous prostate adenocarcinoma represents &lt;0.1% of prostate cancers. To our knowledge, no previous report has described the 68Ga‐PSMA‐PET characteristics of this entity at the primary site. We present a case of a fit 85‐year‐old with PSA 0.55 ng/mL and ISUP grade 4 acinar adenocarcinoma with mucinous features on biopsy. 68Ga‐PSMA‐PET revealed an intensely avid primary lesion in the right prostate (SUVmax 10.9), concordant with biopsy findings and encompassing both the PI‐RADS 5 lesion identified on MRI and a PI‐RADS 1 lesion that presumably represented the mucinous component. The patient was treated with definitive radiotherapy to the prostate and lymph nodes with 6 months of androgen deprivation therapy.</description><identifier>ISSN: 1754-9477</identifier><identifier>EISSN: 1754-9485</identifier><identifier>DOI: 10.1111/1754-9485.13327</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>adenocarcinoma ; Deprivation ; Medical imaging ; mucinous ; Prostate ; Prostate cancer ; PSMA‐PET ; Radiation therapy</subject><ispartof>Journal of medical imaging and radiation oncology, 2022-08, Vol.66 (5), p.637-640</ispartof><rights>2021 The Royal Australian and New Zealand College of Radiologists</rights><rights>Copyright © 2022 The Royal Australian and New Zealand College of Radiologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2697-acbf0caef06bd9478e19b88861d42fc7edb938ebd43cbb456b91143ca4a5a7a63</cites><orcidid>0000-0003-2092-7922 ; 0000-0003-4193-9682 ; 0000-0003-0801-0513 ; 0000-0002-7629-504X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Horsley, Patrick J.</creatorcontrib><creatorcontrib>Sheehan‐Dare, Gemma</creatorcontrib><creatorcontrib>Mastrocostas, Katerina</creatorcontrib><creatorcontrib>Fung, Caroline</creatorcontrib><creatorcontrib>Kneebone, Andrew</creatorcontrib><creatorcontrib>Eade, Thomas N.</creatorcontrib><creatorcontrib>Emmet, Louise</creatorcontrib><creatorcontrib>Lalak, Andre</creatorcontrib><creatorcontrib>Hruby, George</creatorcontrib><title>Prostate adenocarcinoma with mucinous features – is it PSMA avid?</title><title>Journal of medical imaging and radiation oncology</title><description>Summary Mucinous prostate adenocarcinoma represents &lt;0.1% of prostate cancers. To our knowledge, no previous report has described the 68Ga‐PSMA‐PET characteristics of this entity at the primary site. We present a case of a fit 85‐year‐old with PSA 0.55 ng/mL and ISUP grade 4 acinar adenocarcinoma with mucinous features on biopsy. 68Ga‐PSMA‐PET revealed an intensely avid primary lesion in the right prostate (SUVmax 10.9), concordant with biopsy findings and encompassing both the PI‐RADS 5 lesion identified on MRI and a PI‐RADS 1 lesion that presumably represented the mucinous component. The patient was treated with definitive radiotherapy to the prostate and lymph nodes with 6 months of androgen deprivation therapy.</description><subject>adenocarcinoma</subject><subject>Deprivation</subject><subject>Medical imaging</subject><subject>mucinous</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>PSMA‐PET</subject><subject>Radiation therapy</subject><issn>1754-9477</issn><issn>1754-9485</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFUMtOwzAQtBBIlMKZqyXOaePGju0TiiooSEVUPM7W2nGEq7YpdkLVG__AH_IlOAT1yl72oZmd3UHokqQjEmNMOKOJpIKNSJZN-BEaHCbHh5rzU3QWwjJNc0KoHKDpwtehgcZiKO2mNuCN29RrwDvXvOF123VtwJWFpvU24O_PL-wCdg1ePD8UGD5ceX2OTipYBXvxl4fo9fbmZXqXzB9n99NinphJLnkCRlepAVuluS7jKcISqYUQOSnppDLcllpmwuqSZkZrynIt442ZAQoMOOTZEF31e7e-fm9taNSybv0mSqpOgAnJBI-ocY8y8bPgbaW23q3B7xVJVeeU6rxQnS_q16nIYD1j51Z2_x9cFU9Fz_sB0udrQQ</recordid><startdate>202208</startdate><enddate>202208</enddate><creator>Horsley, Patrick J.</creator><creator>Sheehan‐Dare, Gemma</creator><creator>Mastrocostas, Katerina</creator><creator>Fung, Caroline</creator><creator>Kneebone, Andrew</creator><creator>Eade, Thomas N.</creator><creator>Emmet, Louise</creator><creator>Lalak, Andre</creator><creator>Hruby, George</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-2092-7922</orcidid><orcidid>https://orcid.org/0000-0003-4193-9682</orcidid><orcidid>https://orcid.org/0000-0003-0801-0513</orcidid><orcidid>https://orcid.org/0000-0002-7629-504X</orcidid></search><sort><creationdate>202208</creationdate><title>Prostate adenocarcinoma with mucinous features – is it PSMA avid?</title><author>Horsley, Patrick J. ; Sheehan‐Dare, Gemma ; Mastrocostas, Katerina ; Fung, Caroline ; Kneebone, Andrew ; Eade, Thomas N. ; Emmet, Louise ; Lalak, Andre ; Hruby, George</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2697-acbf0caef06bd9478e19b88861d42fc7edb938ebd43cbb456b91143ca4a5a7a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>adenocarcinoma</topic><topic>Deprivation</topic><topic>Medical imaging</topic><topic>mucinous</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>PSMA‐PET</topic><topic>Radiation therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horsley, Patrick J.</creatorcontrib><creatorcontrib>Sheehan‐Dare, Gemma</creatorcontrib><creatorcontrib>Mastrocostas, Katerina</creatorcontrib><creatorcontrib>Fung, Caroline</creatorcontrib><creatorcontrib>Kneebone, Andrew</creatorcontrib><creatorcontrib>Eade, Thomas N.</creatorcontrib><creatorcontrib>Emmet, Louise</creatorcontrib><creatorcontrib>Lalak, Andre</creatorcontrib><creatorcontrib>Hruby, George</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of medical imaging and radiation oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horsley, Patrick J.</au><au>Sheehan‐Dare, Gemma</au><au>Mastrocostas, Katerina</au><au>Fung, Caroline</au><au>Kneebone, Andrew</au><au>Eade, Thomas N.</au><au>Emmet, Louise</au><au>Lalak, Andre</au><au>Hruby, George</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostate adenocarcinoma with mucinous features – is it PSMA avid?</atitle><jtitle>Journal of medical imaging and radiation oncology</jtitle><date>2022-08</date><risdate>2022</risdate><volume>66</volume><issue>5</issue><spage>637</spage><epage>640</epage><pages>637-640</pages><issn>1754-9477</issn><eissn>1754-9485</eissn><abstract>Summary Mucinous prostate adenocarcinoma represents &lt;0.1% of prostate cancers. To our knowledge, no previous report has described the 68Ga‐PSMA‐PET characteristics of this entity at the primary site. We present a case of a fit 85‐year‐old with PSA 0.55 ng/mL and ISUP grade 4 acinar adenocarcinoma with mucinous features on biopsy. 68Ga‐PSMA‐PET revealed an intensely avid primary lesion in the right prostate (SUVmax 10.9), concordant with biopsy findings and encompassing both the PI‐RADS 5 lesion identified on MRI and a PI‐RADS 1 lesion that presumably represented the mucinous component. The patient was treated with definitive radiotherapy to the prostate and lymph nodes with 6 months of androgen deprivation therapy.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/1754-9485.13327</doi><tpages>640</tpages><orcidid>https://orcid.org/0000-0003-2092-7922</orcidid><orcidid>https://orcid.org/0000-0003-4193-9682</orcidid><orcidid>https://orcid.org/0000-0003-0801-0513</orcidid><orcidid>https://orcid.org/0000-0002-7629-504X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1754-9477
ispartof Journal of medical imaging and radiation oncology, 2022-08, Vol.66 (5), p.637-640
issn 1754-9477
1754-9485
language eng
recordid cdi_proquest_journals_2697589587
source Wiley-Blackwell Read & Publish Collection
subjects adenocarcinoma
Deprivation
Medical imaging
mucinous
Prostate
Prostate cancer
PSMA‐PET
Radiation therapy
title Prostate adenocarcinoma with mucinous features – is it PSMA avid?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A32%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostate%20adenocarcinoma%20with%20mucinous%20features%20%E2%80%93%20is%20it%20PSMA%20avid?&rft.jtitle=Journal%20of%20medical%20imaging%20and%20radiation%20oncology&rft.au=Horsley,%20Patrick%20J.&rft.date=2022-08&rft.volume=66&rft.issue=5&rft.spage=637&rft.epage=640&rft.pages=637-640&rft.issn=1754-9477&rft.eissn=1754-9485&rft_id=info:doi/10.1111/1754-9485.13327&rft_dat=%3Cproquest_cross%3E2697589587%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2697-acbf0caef06bd9478e19b88861d42fc7edb938ebd43cbb456b91143ca4a5a7a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2697589587&rft_id=info:pmid/&rfr_iscdi=true